Swollen joint count in psoriatic arthritis is associated with progressive radiological damage in hands and feet

Clinical and Experimental Rheumatology

Volumn 30, Issue 1, 2012, Pages 45-50

  Simon, Pierre ^a   Pföhler, Claudia ^a   Bergner, Raoul ^b   Schreiber, Martin ^a   Pfreundschuh, Michael ^a   Assmann, Gunter ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Department of Rheumatology   (Germany)

Author keywords

psoriatic arthritis; Radiography; Risk factors; Tumour necrosis factor alpha inhibitors

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RADIATION HAZARD; RADIATION INJURY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FOOT; HAND; HUMANS; JOINTS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862490444     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. SHBEEB M, URAMOTO KM, GIBSON LE, O'FALLON WM, GABRIEL SE: The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000; 27: 1247-50.
2. GLADMAN DD, ANTONI C, MEASE PJ, CLEGG DO, NASH P: Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005; 64 (Suppl. 2): ii14-ii17.
3. GLADMAN DD, SHUCKETT R, RUSSELL ML, THORNE JC, SCHACHTER RK: Psoriatic arthritis - an analysis of 220 patients. Q J Med 1987; 62: 127-41.
4. KANE D, STAFFORD L, BRESNIHAN B, FITZGERALD O: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003; 42: 1460-8.
5. GLADMAN DD: Disability and quality of life considerations: psoriatic arthritis. In Psoriasis and psoriatic arthritis: an integrated approach. Edited by: GORDON GB, RUDERMAN E. Heidelberg: Springer-Verlag; 2005: 118-23.
6. WONG K, GLADMAN DD, HUSTED J, LONG JA, FAREWELL VT: Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997; 40: 1868-72.
7. MEASE PJ, SHARP JI, ORY P et al.: Adalimumab Treatment Effects on Radiographic Progression of Joint Disease in Patients with Psoriatic Arthritis: Results from ADEPT. Ann Rheum Dis 2005; 64 (SIII): 320.
8. MEASE PJ, KIVITZ AJ, BURCH FX et al.: Etanercept Treatment of Psoriatic Arthritis: Safety, Efficacy, and Effect on Disease Progression. Arthritis Rheum 2004; 50: 2264-72.
9. KAVANAUGH A, ANTONI CE, GLADMAN DD et al.: The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): Results of radiographic analyses after 1 year. Ann Rheum Dis 2006; 65: 1038-43.
10. MEASE PJ, ANTONI CE, GLADMAN DD, TAYLOR WJ: Psoriatic arthritis assesment tools in clinical trials. Ann Rheum Dis 2005; 64 (Suppl. II): ii49-ii54.
11. BOND SJ, FAREWELL VT, SCHENTAG CT, GLADMAN DD: Predictors for radiological damage in psoriatic arthritis: results from a single centre. Ann Rheum Dis 2007; 66: 370- 6.
12. BUTT C, PEDDLE L, GREENWOOD C, HAMILTON S, GLADMAN DD, RAHMAN P: Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Res Ther 2006; 8: R27.
13. DUFFIN KC, CHANDRAN V, GLADMAN DD, KRUEGER GG, ELDER JT, RAHMAN P: Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol 2008; 35: 1449-53.
14. BALDING J, KANE D, LINGSTONE W et al.: Cytokine gene polymorphisms: associations with psoriasis arthritis susceptibility and severity. Arthritis Rheum 2003; 48: 1408-13.
15. RAHMAN P, SIANNIS F, BUTT C et al.: Metaanalysis of TNF-alpha polymorphisms in caucasian psoriatic arthritis populations. Ann Rheum Dis 2005; 64 (SIII): 325.
16. TAYLOR W, GLADMAN D, HELLIWELL P et al.: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73.
17. VAN DER HEIJDE D, SHARP J, WASSENBERG S, GLADMAN DD: Psoriatic arthritis imaging: a review of scoring methods. Ann Rheum Dis 2005; 64 (Suppl. II): ii61-ii64.
18. GLADMAN DD, MEASE PJ, STRAND VIBEKE et al.: Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007; 34: 1167-70.
19. GLADMAN DD, MEASE PJ, HEALY P et al.: Outcome measures in psoriatic arthritis. J Rheumatol 2007; 34: 1156-66.
20. SIANNIS F, FAREWELL VT, COOK RJ, SCHENTAG CT, GLADMAN DD: Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis 2006; 65: 478-81.
21. QUEIRO-SILVA R, TORRE-ALONSO JC, TINTURÉ-EGUREN T, LÓPEZ-LAGUNAS I: A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003; 62: 68-70.
22. NASH P, CLEGG DO: Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis 2005; 64: ii74-ii77.
23. MEASE PJ: Psoriatic arthritis therapy advances. Curr Opin Rheumatol 2005; 17: 426-32.
24. GLADMAN DD: Traditional and newer therapeutic options for psoriatic arthritis: Evidencebased review. Drugs 2005; 65: 1223-38.
25. CRESSWELL L, CHANDRAN V, FAREWELL VT, GLADMAN DD: Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis. Ann Rheum Dis 2011; 70: 305-8.
26. CEPONIS A, KAVANAUGH A: Use of methotrexate in patients with psoriatic arthritis. Clin Exp Rheumatol 2010; 28 (Suppl. 61): S132-7
27. CHIMENTI MS, PAPOUTSAKI M, TEOLI M, ZANGRILLI A, PERRICONE R, CHIMENTI S: Radiologically significant Joint Improvement In A Patient Affected By Psoriatic Arthritis Treated With Adalimumab. Clin Exp Rheumatol 2009; 27: 1056.